申请人:Hb Therapeutics Inc.
公开号:US20210115064A1
公开(公告)日:2021-04-22
The present invention relates to the field of anti-cancer compounds. More particularly, the invention relates to a family of benzothiazolyi urea or thiorurea compound useful as such agents. The present invention also relates to methods for treating cancers using these compounds.